sh-tetrapeptide-38 trifluoroacetate은 임신 중 안전한가요?
No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
Related ingredients
Frequently asked questions
- sh-tetrapeptide-38 trifluoroacetate은 임신 중 안전한가요?
- No harmonised CLP reproductive classification located (ECHA Annex VI). No SCCS or CIR safety assessment or peer‑reviewed reproductive/toxicology studies identified for 'sh-tetrapeptide-38 trifluoroacetate' or tetrapeptide-38 indicating reproductive hazard. Peptides of this size are generally polar and have low dermal/systemic absorption in the absence of penetration enhancers, supporting negligible exposure from topical cosmetic use (sources searched: ECHA Annex VI, SCCS/CIR databases, PubMed, ECHA registration/CosIng, PubChem, EWG).
- sh-tetrapeptide-38 trifluoroacetate은 모유 수유 중 안전한가요?
- No data found indicating systemic exposure, transfer into breastmilk, or lactation toxicity. Given the lack of reproductive or developmental hazard data and expected low dermal absorption of short peptides, exposure via breastmilk is considered negligible for topical cosmetic use (sources searched: SCCS/CIR, PubMed, PubChem, CosIng, ECHA).
- sh-tetrapeptide-38 trifluoroacetate은 아기 피부에 안전한가요?
- No infant‑specific reproductive or toxicity data found. Mechanistic/toxic effects not identified. Exposure rating increased by +1 for baby skin relative to adults because infants have an immature skin barrier and higher surface‑area‑to‑weight ratio; although adult dermal absorption is considered negligible, infant exposure is plausibly low but measurable for topical application. No evidence found of specific hazard to infants aged 0–3 years (sources searched: PubMed, CosIng, ECHA, PubChem, EWG).
- VeriMom은 sh-tetrapeptide-38 trifluoroacetate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 sh-tetrapeptide-38 trifluoroacetate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 sh-tetrapeptide-38 trifluoroacetate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.